Pharmacokinetics and relative bioavailability of carboxyamido-triazole with respect to food and time of administration: Use of a single model for simultaneous determination of changing parameters

Journal of Pharmacokinetics and Biopharmaceutics

Volumn 26, Issue 6, 1998, Pages 673-687

  Bauer, Kenneth S ^a   Kohn, Elise C ^a   Lush, Richard M ^a   Steinberg, Seth M ^a   Davis, Pat ^a   Kohler, David ^a   Reed, Eddie ^a   Figg, William D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Bioavailability; Carboxyamido triazole; Chronopharmacology; Food; Pharmacokinetics

Indexed keywords

5 AMINO 1 [3,5 DICHLORO 4 (4 CHLOROBENZOYL)BENZYL] 1H 1,2,3 TRIAZOLE 4 CARBOXAMIDE; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; CHRONOPHARMACOLOGY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG STRUCTURE; FEMALE; FOOD DRUG INTERACTION; HUMAN; LIPID DIET; MALE; MODEL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; COHORT STUDIES; CROSS-OVER STUDIES; FEMALE; FOOD-DRUG INTERACTIONS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; TRIAZOLES;

EID: 0032464992     PISSN: 0090466X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020750923542     Document Type: Article

References (16)

1. E. C. Kohn and L. A. Liotta. L651582: A novel antiproliferative and antimetastasis agent. J. Natl. Cancer Inst. 82:54-60 (1990).
2. W. J. Wasilenko, A. J. Palad, K. D. Somers, P. F. Blackmore, E. C. Kohn, J. S. Rhim, G. L. Wright, and P. F. Schellhammer. Effect of the calcium influx inhibitor carboxyamido-triazole on the proliferation and invasiveness of human prostate tumor cell lines. Int. J. Cancer 68:259-264 (1996).
3. P. A. Lambert, K. D. Somers, E. C. Kohn, and R. R. Perry. Antiproliferative and antiinvasive effects of carboxyamido-triazole on breast cancer cell lines. Surgery 122:372-379 (1997).
4. E. C. Kohn, R. Alessandro, J. Spoonster, R. P. Wersto, and L. A. Liotta. Angiogenesis: Role of calcium-mediated signal transduction. Proc. Natl. Acad. Sci. U.S. 92:1307-1311 (1995).
5. E. C. Kohn, W. Jacobs, Y. S. Kim, R. Alessandro, W. G. Stetler-Stevenson, and L. A. Liotta. Calcium influx modulates expression of matrix metalloproteinase-2 (72-kDa type IV colagenase, gelatinase A)*. J. Biol. Chem. 269:21505-21511 (1994).
6. E. C. Kohn, E. Reed, G. A. Sarosy, M. Christian, C. J. Link, K. Cole, W. D. Figg, P. A. Davis, J. Jacob, B. Goldspiel, and L. A. Liotta. Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers. Cancer Res. 56:569-573 (1996).
7. J. Berlin, K. D. Tutsch, P. Hutson, J. Cleary, R. P. Rago, R. Z. Arzoomanian, D. Alberti, C. Feierabend, and G. Wilding. Phase I clinical and pharmacokinetic study of oral carboxyamidotriazole, a signal transduction inhibitor. J. Clin. Oncol. 15:781-789 (1997).
8. E. C. Kohn, W. D. Figg, G. A. Sarosy, K. S. Bauer, P. A. Davis, M. J. Soltis, A. Thompkins, L. A. Liotta, and E. Reed. Phase I trial of micronized formulation carboxyamidotriazole in patients with refractory solid tumors: Pharmacokinetics, clinical outcome, and comparison of formulations. J. Clin. Oncol. 15:1985-1993 (1997).
9. J. Berlin, K. D. Tutsch, R. Z. Arzoomanian, D. Alberti, C. Feierabend, K. Simon, P. Hutson, J. Cleary, J. Stewart, and G. Wilding. Phase I clinical and pharmacokinetic trial of an oral micronized formulation of carboxyamidotriazole (CAI). Proc. Am. Assoc. Cancer Res. 37:164 (all33) (1996).
10. B. R. Simmons, K. S. Bauer, N. A. McCall, E. C. Kohn, and W. D. Figg. An optimized method for the quantitation of carboxyamido-triazole (CAI) in human plasma with solid phase extraction and reversed phase HPLC. Anal. Lett. 30:2009-2021 (1997).
11. M. Gibaldi and D. Perrier. Pharmacokinetics, 2nd Ed., Dekker, New York (1982).
12. D. Z. D'Argenia and A. Schumitzky. A program package for simulation and parameter estimation in pharmacokinetic systems. Comput. Prog. Biomed. 9:115-134 (1979).
13. K. Yamaoka, J. Nakagawa, and T. Uno. Application of Aikaike's information criteria (AIC) in the evaluation of linear pharmacokinetic equations. J. Pharmacokin. Biopharm. 2:165-175 (1978).
14. G. G. Koch. The use of non-parametric methods in the statistical analysis of the two-period change-over design. Biometrics 28:577-584 (1972).
15. Y. Hochberg. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 75:800-802 (1988).
16. L. K. Ludden, J. M. Strong, E. C. Kohn, and J. M. Collins. Similarity of metabolism for CAI (NSC 609974) in human liver tissue in vitro and in humans in vivo. Clin. Cancer Res. 1:399-405 (1995).